A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

被引:816
作者
Lee, JS
Heo, J
Libbrecht, L
Chu, IS
Kaposi-Novak, P
Calvisi, DF
Mikaelyan, A
Roberts, LR
Demetris, AJ
Sun, ZT
Nevens, F
Roskams, T
Thorgeirsson, SS
机构
[1] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA
[2] Katholieke Univ Leuven, Dept Morphol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Dept Mol Pathol, B-3000 Louvain, Belgium
[4] Korea Res Inst Biosci & Biotechnol, Natl Genome Informat Ctr, Taejon 305333, South Korea
[5] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[6] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplant Inst, Pittsburgh, PA 15213 USA
[7] Chinese Acad Med Sci, Inst Canc, Natl Lab Mol Oncol, Beijing 100021, Peoples R China
关键词
D O I
10.1038/nm1377
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The variability in the prognosis of individuals with hepatocellular carcinoma (HCC) suggests that HCC may comprise several distinct biological phenotypes. These phenotypes may result from activation of different oncogenic pathways during tumorigenesis and/or from a different cell of origin. Here we address whether the transcriptional characteristics of HCC can provide insight into the cellular origin of the tumor. We integrated gene expression data from rat fetal hepatoblasts and adult hepatocytes with HCC from human and mouse models. Individuals with HCC who shared a gene expression pattern with fetal hepatoblasts had a poor prognosis. The gene expression program that distinguished this subtype from other types of HCC included markers of hepatic oval cells, suggesting that HCC of this subtype may arise from hepatic progenitor cells. Analyses of gene networks showed that activation of AP-1 transcription factors in this newly identified HCC subtype might have key roles in tumor development.
引用
收藏
页码:410 / 416
页数:7
相关论文
共 41 条
[1]
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]
The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[3]
Focus on hepatocellular carcinoma [J].
Bruix, J ;
Boix, L ;
Sala, M ;
Llovet, JM .
CANCER CELL, 2004, 5 (03) :215-219
[4]
Changing views of the role of matrix metalloproteinases in metastasis [J].
Chambers, AF ;
Matrisian, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1260-1270
[5]
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis [J].
Chang, C ;
Werb, Z .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S37-S43
[6]
Ezrin ... a metastatic detERMinant? [J].
Curto, M ;
McClatchey, AI .
CANCER CELL, 2004, 5 (02) :113-114
[7]
Dabeva MD, 2003, SEMIN LIVER DIS, V23, P349
[8]
DURNEZ A, IN PRESS HEPATOLOGY
[9]
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 [J].
Eferl, R ;
Ricci, R ;
Kenner, L ;
Zenz, R ;
David, JP ;
Rath, M ;
Wagner, EF .
CELL, 2003, 112 (02) :181-192
[10]
EL SH, 1999, NEW ENGL J MED, V340, P745